Emerging Infectious Disease ISSN: 1080-6059

Linezolid Dependence in Staphylococcus epidermidis Bloodstream Isolates

Spyros Pournaras

, Eleni Ntokou, Olympia Zarkotou, Kyriaki Ranellou, Katerina Themeli-Digalaki, Constantinos Stathopoulos, and Athanassios Tsakris

Author affiliations: Author affiliations: University of Thessaly Medical School, Larissa, Greece (S. Pournaras, E. Ntokou); Tzaneio General Hospital, Piraeus, Greece (O. Zarkotou, K. Themeli-Digalaki); University of Athens Medical School, Athens, Greece (K. Ranellou, A. Tsakris); University of Patras School of Medicine, Patras, Greece (C. Stathopoulos)

Main Article

Figure 1

LRSE isolated from patients with bloodstream infections, Greece, 2008–2010. Effect of growth under exposure to linezolid at 128 μg/mL is shown for the 5 highly LRSE: A) A2562[1], B) E371, C) A2864, D) 217, and E) 605–2. LRSE, linezolid-resistant Staphylococcus epidermidis.

Figure 1. . . LRSE isolated from patients with bloodstream infections, Greece, 2008–2010. Effect of growth under exposure to linezolid at 128 μg/mL is shown for the 5 highly LRSE: A) A2562[1], B) E371, C) A2864, D) 217, and E) 605–2. LRSE, linezolid-resistant Staphylococcus epidermidis.

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.